NIHR Bioresource: Advancing Rare Disease research with Omics technologies.
About the project
-
Developing a comprehensive multi-omics resource of 1,000 rare genetic disease patients
-
Covers 15+ disease areas
Omics datasets generated
-
Genomics
-
Short-read whole genome sequencing (30x coverage)
-
Long-read whole genome sequencing (30x coverage)
-
Transcriptomics
-
RNA sequencing across 4 immune/hematopoietic cell types: Neutrophils, Monocytes, CD4 T-cells, Platelets
-
Proteomics
-
Mass spectrometry profiling on the 4 cell types + plasma
-
Other data
-
Whole blood counts
Impact for Rare Disease Research
-
First-in-kind deep multi-omics dataset across genomics, epigenomics, transcriptomics & proteomics
-
Enables discovery of novel mechanisms and biomarkers
-
Improves diagnostic yield and understanding of disease biology